✉news HealthMedicine first seen 11 h ago, last 2 h ago, peak #6
First Participant Enrolled in VITALS ALS Trial
Original: Dartmouth’s Geisel School of Medicine and the Sean M. Healey & AMG Center for Integrated ALS Care and Discovery Announce First Participant Enrolled in VITALS Trial
Dartmouth's Geisel School of Medicine and the Sean M. Healey & AMG Center for Integrated ALS Care and Discovery have announced that the first participant has been enrolled in the VITALS trial. The announcement marks the start of a clinical study aimed at advancing care and discovery in ALS, a progressive neurodegenerative disease with limited treatment options. Further details on the trial's design and outcomes have not yet been reported.
Why now: The announcement of the first participant signals the launch of a new clinical trial for ALS, an area of high unmet medical need.
Dartmouth Geisel School of MedicineSean M. Healey & AMG Center for Integrated ALS Care and DiscoveryVITALS trial
Rank over time, top of the chart is #1. 3 snapshots from 4 h ago to 2 h ago.
Evidence
- Dartmouth’s Geisel School of Medicine and the Sean M. Healey & AMG Center for Integrated ALS Care and Discovery Announce First Participant Enrolled in VITALS Trial · Geisel School of Medicine at Dartmouth
API: https://socialmediatrends-api.osmike.com/v1/trends/1558447